Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy
- 1 January 2009
- journal article
- Published by Informa UK Limited in Scandinavian Journal of Infectious Diseases
- Vol. 41 (9), 689-699
- https://doi.org/10.1080/00365540903095358
Abstract
Our objective was to estimate HCV clinical burden over time in Italy. A national age-specific HCV prevalence in 1995 was obtained from studies conducted in general population samples and intravenous drug users. Age profile of new HCV infections and trend of incidence since 1985 were derived from a database of reported acute HCV infections. These incidence and prevalence data were used to estimate HCV burden from 1950 to 2030 by mathematical modelling. Different rates of HCV related liver disease progression were tested to assess the robustness of estimates. It is estimated that HCV had a major spread in Italy in 1945-1969. HCV RNA-positive subjects peaked around 1970; their prevalence in 2005 was 3.2%, 58% of them being >65 y of age. The number of individuals with HCV related cirrhosis and that of HCV liver related deaths peaked in 1980-1985. In 2005, they were approximately 230,000 (range 150,000-240,000, according to lower or higher disease progression rates) and approximately 7,000 (range 2200-12,300), respectively: both will be halved by 2025. In conclusion, unlike other industrialized countries, the burden of clinically relevant HCV-positive cases in Italy is already on the decline and will further reduce in the future. This is due to differences in the age-specific prevalence, most of HCV-positive Italians currently being >65 y of age.Keywords
This publication has 57 references indexed in Scilit:
- The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Modeling the current and future disease burden of hepatitis C among injection drug users in ScotlandHepatology, 2005
- Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis CJournal of Hepatology, 2005
- The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 casesJournal of Medical Virology, 2005
- Global Burden of Disease (GBD) for Hepatitis CThe Journal of Clinical Pharmacology, 2004
- Liver transplantation: the Italian experienceDigestive and Liver Disease, 2002
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United StatesHepatology, 2000
- Modeling the hepatitis C virus epidemic in franceHepatology, 1999
- Estimating the prevalence of injecting drug users on the basis of Markov models of the HIV/AIDS epidemic: applications to Italian data.Health Care Management Science, 1999